« Back
Home /
O-BOC-N-Pyruvyl Docetaxel

O-BOC-N-Pyruvyl Docetaxel

Item no.	TRC-O100500-5mg
Manufacturer	Toronto Research Chemicals
CASRN	1021489-55-3
Amount	5 mg
Quantity options	0.5 mg 1 mg 2.5 mg 25 mg 5 mg
Category	Reagents & Chemicals Other Chemicals
Type	Biochemicals
Specific against	other
InCHI	1S/C46H55NO16/c1-23-28(59-40(55)34(60-41(56)63-42(4,5)6)32(47-38(53)24(2)48)26-16-12-10-13-17-26)21-46(57)37(61-39(54)27-18-14-11-15-19-27)35-44(9,36(52)33(51)31(23)43(46,7)8)29(50)20-30-45(35,22-58-30)62-25(3)49/h10-19,28-30,32-35,37,50-51,57H,20-22H2,1-
Smiles	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](OC(=O)OC(C)(C)C)[C@@H](NC(=O)C(=O)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Benzenepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]oxy]-β-[(1,2-dioxopropyl)amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; O-BOC N-Pyruvyl Docetaxel; (2aR,4R,4aS,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,9,11,12,12b-pentahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5,6-dione 12b-acetate 12-benzoate 9-ester with (2R,3S)-2-(tert-butoxycarbonyloxy)-3-(2-oxopropanamido)-3-phenylpropanoic acid
Shipping condition	Room temperature
Hazard information	Controlled Products: Not Controlled \| UN #: UNCHECK
Available
Manufacturer - Category	Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
Country of Origin	Canada
Shipping Temperature	RT\|Room Temperature
Molecular Weight	877, 93
Controlled Products	Not Controlled
MSDS Availability	TRUE
UN #	UNCHECK
Manufacturer - Synonym	Benzenepropanoic acid, ?-[[(1, 1-dimethylethoxy)carbonyl]oxy]-?-[(1, 2-dioxopropyl)amino]-, (2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-4, 6, 11-trihydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl ester, (?R, ?S)-, O-BOC N-Pyruvyl Docetaxel, (2aR, 4R, 4aS, 9S, 11S, 12S, 12aR, 12bS)-1, 2a, 3, 4, 4a, 6, 9, 10, 11, 12, 12a, 12b-Dodecahydro-4, 9, 11, 12, 12b-pentahydroxy-4a, 8, 13, 13-tetramethyl-7, 11-methano-5H-cyclodeca[3, 4]benz[1, 2-b]oxet-5, 6-dione 12b-acetate 12-benzoate 9-ester with (2R, 3S)-2-(tert-butoxycarbonyloxy)-3-(2-oxopropanamido)-3-phenylpropanoic acid

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

TRC-O100500-5mg-safety-datasheet.pdf